Dr. Dismuke-Greer will explore the role of CT and MRI as benchmark cost-effectiveness biomarkers for future comparison with non-imaging biomarkers in the diagnosis and management of Traumatic Brain Injury. Dr. Dismuke-Greer will provide findings on the per unit as well as the impact of CT and MRI on inpatient, outpatient and pharmacy costs of Vetereans diagnosed with Traumatic Brain Injury in the Veterans Health Administration.
Understand the reason for comparing new TBI biomarker pricing with existing diagnostic costs for future cost-effectiveness analysis
Understand the association of TBI severity with utilization of CT and MRI in TBI management in veterans
Understand the association of CT and MRI use with VA inpatient, outpatient and pharmacy costs in veterans diagnosed with TBI